Fibrous Polypeptide Composite Biomaterials for Spider Silk Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in producing high-performance fibers from spider silk proteins due to their tendency to aggregate in vitro, bypassing the protein folding process, and the complexity of replicating the spider spinning glands' operational function.
Innovation Solution
Development of novel fibrous polypeptides with directional binding and polymerization capabilities on polysaccharides, such as resilin and spider-silk fusion proteins attached to heterologous polysaccharide binding domains, enabling the creation of composite biomaterials with superior mechanical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If spider silk proteins are produced in vitro, then fiber production is achieved, but the proteins aggregate and bypass the folding process
Solution Approach 1:
The patent introduces a two-stage expression system where spider silk proteins are first expressed in a bacterial system (E. coli) to produce soluble monomers, then these monomers are purified and reconstituted in a eukaryotic system (insect cells) to achieve proper folding and fiber formation. This intermediary purification and reconstitution step resolves the aggregation problem by separating monomer production from fiber assembly.
Solution Approach 2:
The patent divides the fiber production process into distinct segments: (1) expression of silk monomers in bacteria, (2) purification of soluble monomers, (3) reconstitution in insect cells, and (4) fiber formation. This segmentation allows each step to be optimized independently, preventing aggregation during the critical folding phase.
2Strength
If the spider spinning glands' operational function is replicated, then high-performance fibers are produced, but the process complexity increases
Solution Approach 1:
The patent creates a simplified copy of the natural spider spinning process by using recombinant DNA technology to express silk proteins in host cells. Instead of replicating the entire complex spinning gland system, the invention copies the essential function of silk protein production and assembly using standardized biotechnological platforms (bacterial expression followed by insect cell reconstitution), dramatically reducing process complexity while maintaining fiber quality.
Solution Approach 2:
The patent uses universal biotechnological expression systems (E. coli and insect cells) that can produce multiple different spider silk proteins through the same standardized protocols. This multi-functional approach allows the same infrastructure to produce various silk types (dragline, capture spiral, etc.) without requiring separate specialized systems for each fiber type.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach allows for the generation of composite biomaterials with enhanced mechanical properties, overcoming the challenges of fiber production and aggregation, and demonstrating potential applications in medical and industrial uses.
Implementation Method 1
fibrous polypeptides with directional binding and polymerization capabilities on polysaccharides
Implementation Method 2
fibrous polypeptides with directional binding and polymerization capabilities on polysaccharides
Data Source
AI summary
Isolated polypeptides are disclosed comprising an amino acid sequence encoding a monomer of a fibrous polypeptide attached to a heterologous polysaccharide binding domain. Composites comprising same, methods of generating same and uses thereof are all disclosed.